A business in context

DMAC research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-20 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-08-10 · 0001760123-26-000004

  2. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001437749-26-026792

  3. 8-K · Current report

    Report date 2026-08-10 · 0001437749-26-026790 · Items 2.02,9.01

  4. 4 · Ownership change

    Report date 2026-06-01 · 0001872863-26-000004

  5. 4 · Ownership change

    Report date 2026-06-01 · 0001760123-26-000002

  6. 4 · Ownership change

    Report date 2026-06-01 · 0001759855-26-000004

  7. 4 · Ownership change

    Report date 2026-06-01 · 0001759822-26-000004

  8. 4 · Ownership change

    Report date 2026-06-01 · 0001643127-26-000002

  9. 4 · Ownership change

    Report date 2026-06-01 · 0001490476-26-000002

  10. 4 · Ownership change

    Report date 2026-06-01 · 0001451038-26-000002

  11. 8-K · Current report

    Report date 2026-05-20 · 0001437749-26-018106 · Items 5.07

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001437749-26-015220

  13. 8-K · Current report

    Report date 2026-05-06 · 0001437749-26-015218 · Items 2.02,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-05-20 · 0001437749-26-010879

  15. 8-K · Current report

    Report date 2026-03-30 · 0001437749-26-010409 · Items 2.02,9.01

  16. 10-K · Annual report

    Report date 2025-12-31 · 0001437749-26-010342

  17. 8-K · Current report

    Report date 2026-01-05 · 0001437749-26-000175 · Items 8.01

  18. 8-K · Current report

    Report date 2025-12-18 · 0001437749-25-038211 · Items 7.01,8.01,9.01

  19. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001437749-25-034469

  20. 8-K · Current report

    Report date 2025-11-12 · 0001437749-25-034467 · Items 2.02,9.01

  21. 8-K · Current report

    Report date 2025-08-12 · 0001437749-25-026286 · Items 1.01,9.01

  22. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001437749-25-026207

  23. 8-K · Current report

    Report date 2025-08-12 · 0001437749-25-026205 · Items 2.02,9.01

  24. 8-K · Current report

    Report date 2025-08-04 · 0001437749-25-024956 · Items 5.02,7.01,8.01,9.01

  25. 8-K · Current report

    Report date 2025-07-21 · 0001437749-25-023048 · Items 1.01,3.02,8.01,9.01

  26. 8-K · Current report

    Report date 2025-07-17 · 0001437749-25-022877 · Items 7.01,9.01

  27. 8-K · Current report

    Report date 2025-05-15 · 0001437749-25-017239 · Items 5.07,9.01

  28. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001437749-25-016488

  29. 8-K · Current report

    Report date 2025-05-13 · 0001437749-25-016487 · Items 2.02,9.01

  30. DEF 14A · Proxy statement

    Report date 2025-05-15 · 0001437749-25-009696

  31. 10-K · Annual report

    Report date 2024-12-31 · 0001437749-25-008018

  32. 8-K · Current report

    Report date 2025-03-17 · 0001437749-25-008014 · Items 2.02,9.01

  33. 8-K · Current report

    Report date 2025-02-28 · 0001437749-25-006379 · Items 5.02

  34. 8-K · Current report

    Report date 2025-02-20 · 0001437749-25-004891 · Items 5.02,7.01,9.01

  35. 10-Q · Quarterly report

    Report date 2024-09-30 · 0001437749-24-034925

  36. 8-K · Current report

    Report date 2024-11-13 · 0001437749-24-034922 · Items 2.02,7.01,9.01

  37. 8-K · Current report

    Report date 2024-08-07 · 0001437749-24-025200 · Items 2.02,9.01

  38. 10-Q · Quarterly report

    Report date 2024-06-30 · 0001437749-24-025198

  39. SC 13G · Ownership disclosure

    0000919574-24-003946

  40. 8-K · Current report

    Report date 2024-06-25 · 0001437749-24-021220 · Items 1.01,3.02,8.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 1 transaction rows1AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

1 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-08-10
2026-08-12
Pauls Dietrich JohnA · Grant / award
Acquired
Voting Common Shares, no par value per share60200.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001401040DiaMedica Therapeutics Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names
  • DiaMedica Inc. · former SEC name · 2007-05-16 to 2014-03-11

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2018-12-31$500.0K$670.9K

Bureau of Labor Statistics · retrieved 2026-10-20 · 9 selected series; gaps remain missing

Explore the CPI history ↗